» Articles » PMID: 12842339

Air Classifier Technology (ACT) in Dry Powder Inhalation. Part 1. Introduction of a Novel Force Distribution Concept (FDC) Explaining the Performance of a Basic Air Classifier on Adhesive Mixtures

Overview
Journal Int J Pharm
Specialties Chemistry
Pharmacology
Date 2003 Jul 5
PMID 12842339
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Air classifier technology (ACT) is introduced as part of formulation integrated dry powder inhaler development (FIDPI) to optimise the de-agglomeration of inhalation powders. Carrier retention and de-agglomeration results obtained with a basic classifier concept are discussed. The theoretical cut-off diameter for lactose of the classifier used, is between 35 and 15 microm for flow rates ranging from 20 to 70 l/min. Carrier retention of narrow size fractions is higher than 80% for flow rates between 30 and 60 l/min, inhalation times up to 6s and classifier payloads between 0 and 30mg. The de-agglomeration efficiency for adhesive mixtures, derived from carrier residue (CR) measurement, increases both with increasing flow rate and inhalation time. At 30 l/min, 60% fine particle detachment can be obtained within 3s circulation time, whereas at 60 l/min only 0.5s is necessary to release more than 70%. More detailed information of the change of detachment rate within the first 0.5s of inhalation is obtained from laser diffraction analysis (LDA) of the aerosol cloud. The experimental results can be explained with a novel force distribution concept (FDC) which is introduced to better understand the complex effects of mixing and inhalation parameters on the size distributions of adhesion and removal forces and their relevance to the de-agglomeration in the classifier.

Citing Articles

Optimization of Carrier-Based Dry Powder Inhaler Performance: A Review.

Mehta T, Najafian S, Patel K, Lacombe J, Chaudhuri B Pharmaceutics. 2025; 17(1).

PMID: 39861744 PMC: 11768101. DOI: 10.3390/pharmaceutics17010096.


Dry powder inhaler design and particle technology in enhancing Pulmonary drug deposition: challenges and future strategies.

Islam N, Suwandecha T, Srichana T Daru. 2024; 32(2):761-779.

PMID: 38861247 PMC: 11555000. DOI: 10.1007/s40199-024-00520-3.


The Optimisation of Carrier Selection in Dry Powder Inhaler Formulation and the Role of Surface Energetics.

Abiona O, Wyatt D, Koner J, Mohammed A Biomedicines. 2022; 10(11).

PMID: 36359226 PMC: 9687551. DOI: 10.3390/biomedicines10112707.


Understanding Carrier Performance in Low-Dose Dry Powder Inhalation: An In VitroIn Silico Approach.

Pinto J, Cachola I, Pinto J, Paudel A Pharmaceutics. 2021; 13(3).

PMID: 33668317 PMC: 8025906. DOI: 10.3390/pharmaceutics13030297.


Agglomerated novel spray-dried lactose-leucine tailored as a carrier to enhance the aerosolization performance of salbutamol sulfate from DPI formulations.

Molina C, Kaialy W, Chen Q, Commandeur D, Nokhodchi A Drug Deliv Transl Res. 2017; 8(6):1769-1780.

PMID: 29260462 PMC: 6280810. DOI: 10.1007/s13346-017-0462-8.